A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)

BACKGROUND: Clostridium difficile is the most common cause of hospital-acquired infections, responsible for >450000 infections annually in the USA. Probiotics provide a promising, well-tolerated adjunct therapy to standard C. difficile infection (CDI) treatment regimens, but there is a paucity of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Antimicrob Chemother
Autori principali: Barker, Anna K, Duster, Megan, Valentine, Susan, Hess, Timothy, Archbald-Pannone, Laurie, Guerrant, Richard, Safdar, Nasia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890711/
https://ncbi.nlm.nih.gov/pubmed/28961980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx254
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi